7MM Diabetes Digital Therapeutics Market: Trends & Innovations 2025-2033 | Most Leading Companies - Welldoc, Inc., Omada Health Inc., Glooko, Inc., Azumio Inc., Abbott Laboratories, mySugr GmbH

The 7MM Digital Therapeutics for Diabetes Market size reached US$ 961.09 million in 2024 and is expected to reach US$ 2,578.46 million by 2033, growing at a CAGR of 11.7% during the forecast period 2025-2033.

7mm-Digital-Therapeutics-For-Diabetes Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/7mm-digital-therapeutics-for-diabetes-market?kb

7mm Digital Therapeutics for Diabetes refers to the development and adoption of software-driven medical interventions designed to prevent, manage, and treat diabetes across the seven major markets (7MM) - the US, France, Germany, Italy, Spain, the UK, and Japan. These digital therapeutics leverage AI, data analytics, and behavioral science to optimize diabetes care, improve patient outcomes, and reduce healthcare costs.

List of the Key Players in the 7mm-Digital-Therapeutics-For-Diabetes Market:

Welldoc, Inc., Omada Health Inc., Glooko, Inc., Azumio Inc., Abbott Laboratories, mySugr GmbH, Dexcom, Inc., Health2Sync, iHealth Labs Inc. and Medtronic plc

Industry Development:

In February 2025, Byram Healthcare, a leading provider of home-based care and a subsidiary of Owens & Minor, introduced ByramConnect, a personalized digital health program powered by the Welldoc App. Leveraging Welldoc's advanced AI capabilities, the program analyzes member data across six health dimensions to enhance outcomes for individuals with type 1 and type 2 diabetes, as well as related chronic conditions such as hypertension, weight management, and cardiovascular risk. ByramConnect offers members actionable insights and reports, enabling seamless communication with their healthcare providers and care teams.

In October 2024, Ascensia Diabetes Care introduced the Eversense 365 continuous glucose monitoring (CGM) system in the U.S., marking the launch of the world's first one-year CGM. Developed by Senseonics Holdings, Inc., Eversense 365 offers uninterrupted, long-term glucose monitoring with exceptional accuracy, empowering users with confidence, convenience, and an improved quality of life. The system features a small sensor fully implanted under the skin, which transmits glucose data to a smart transmitter worn above it. This data is automatically sent every five minutes to a mobile app on the user's smartphone, ensuring real-time monitoring with minimal disruptions.

Growth Forecast Projected:

The Global 7mm-Digital-Therapeutics-For-Diabetes Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2033. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global 7mm-Digital-Therapeutics-For-Diabetes Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/7mm-digital-therapeutics-for-diabetes-market?kb

Segment Covered in the 7mm-Digital-Therapeutics-For-Diabetes Market:

By Product Type: Software Solutions, Mobile Apps, Web-Based Solutions, Hardware Solutions Wearable Devices, Continuous Glucose Monitors, Others

By Application: Type-1 Diabetes, Type-2 Diabetes, Pre-Diabetes

By End-User: Hospitals, Specialty Clinics, Homecare Settings, Others

Regional Analysis for 7mm-Digital-Therapeutics-For-Diabetes Market:

The regional analysis of the 7mm-Digital-Therapeutics-For-Diabetes Market covers key regions including North America, Europe, Asia Pacific Middle East and Africa and South America. The North America with a focus on the U.S., Canada, and Mexico; Europe, highlighting major countries like the U.K., Germany, France, and Italy, along with other nations in the region; Asia-Pacific, covering India, China, Japan, South Korea, and Australia, among others; South America, with emphasis on Colombia, Brazil, and Argentina; and the Middle East & Africa, which includes Saudi Arabia, the U.A.E., South Africa, and other countries. This comprehensive regional breakdown helps identify unique market trends and growth opportunities specific to each area.

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/7mm-digital-therapeutics-for-diabetes-market?kb

People Also Ask:

➠ What is the global sales, production, consumption, import, and export value of the 7mm-Digital-Therapeutics-For-Diabetes market?

➠ Who are the leading manufacturers in the global 7mm-Digital-Therapeutics-For-Diabetes industry? What is their operational status in terms of capacity, production, sales, pricing, costs, gross margin, and revenue?

➠ What opportunities and challenges do vendors in the global 7mm-Digital-Therapeutics-For-Diabetes industry face?

➠ Which applications, end-users, or product types are expected to see growth? What is the market share for each type and application?

➠ What are the key factors and limitations affecting the growth of the 7mm-Digital-Therapeutics-For-Diabetes market?

➠ What are the various sales, marketing, and distribution channels in the global industry?

Browse More Reports: https://www.datamintelligence.com/research-report/7mm-digital-therapeutics-for-diabetes-market

Digital Therapeutics for Neurological Disorders Market - https://www.datamintelligence.com/research-report/digital-therapeutics-for-neurological-disorders-market?kb

Digital Therapeutics for Diabetes Market - https://www.datamintelligence.com/research-report/digital-therapeutics-for-diabetes-market?kb

Digital Therapeutics Market - https://www.datamintelligence.com/research-report/digital-therapeutics-market?kb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.